Schedule 13G ownership disclosure

Voyager Therapeutics Inc

Security class unavailable · CUSIP: 92915B106

Event date: 2015-11-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,176,471
Percent of class
4.5200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001028348-15-000018
Form type
SC 13G
Filer
BROOKSIDE CAPITAL PARTNERS FUND LP
CIK
CIK 1028348
Filed
Nov 18, 2015
Reporting period
Nov 11, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub